Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INOVIO PHARMACEUTICALS, INC.
2016Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results
GL
2016Inovio Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Se..
CI
2016Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
GL
2016Inovio Pharmaceuticals, Inc. Appoints Dr. Ami Shah Brown as Vice President Regulatory A..
CI
2016Inovio will Independently Develop Hepatitis B Immunotherapy
GL
2016Inovio Pharmaceuticals to Develop Hepatitis B DNA Immunotherapy (Ino-1800) Independentl..
CI
2016Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial
GL
2016Inovio Pharmaceuticals, Inc. Doses First Subject in Zika Vaccine Clinical Trial
CI
2016Inovio Pharmaceuticals to Report Second Quarter 2016 Financial Results August 8, 2016
GL
2016Inovio Deploys DNA-based Monoclonal Antibody Technology in Quest to Cure HIV
GL
2016Inovio Pharmaceuticals, Inc. Deploys DNA-Based Monoclonal Antibody Technology in Quest ..
CI
2016Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika ..
GL
2016Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika ..
CI
2016Inovio Pharmaceuticals Files For Offering; Mulls Acquisitions
CI
2016Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses in Non-Human Prima..
CI
2016Inovio Pharmaceuticals to Present at UBS Global Healthcare Conference
GL
2016Inovio Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the ..
CI
2016Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results
GL
2016Inovio Pharmaceuticals Showcases its Broad Pipelineáof DNA-based Immunotherapies, Vacci..
GL
2016Inovio Pharmaceuticals CompletesáAcquisition of Needle-Free Injection Technology
GL
2016Inovio Partners with National Cancer Institute and Mayo Clinic to Initiate Hepatitis C ..
GL
2016Inovio Pharmaceuticals to Report First Quarter 2016 Financial Results May 9, 2016
GL
2016Inovio Ebola Vaccine Generates Robust Immune Responses in Humans
GL
2016Inovio Pharmaceuticals HPV Immunotherapy Selected as “Best Therapeutic Vaccine&rd..
GL
2016Inovio Updates INO-3112 HPV Immunotherapy Development Plan
GL
2016INOVIO PHARMACEUTICALS : DNA-based Monoclonal Antibody and DNA Vaccine Provide 100% Protec..
PU
2016Inovio's DNA-based Monoclonal Antibody and DNA Vaccine Provide 100% Protection Against ..
GL
2016INOVIO PHARMACEUTICALS : Signs Collaborative Research Agreements With Wistar Institute for..
PU
2016Inovio Signs Collaborative Research Agreements With Wistar Institute for DNA-based Imm..
GL
2016Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy fo..
GL
2016Inovio Pharmaceuticals Reports 2015 Fourth Quarter and Year End Financial Results
GL
2016Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, Ph.D., to it..
GL
2016Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2015 Financial Results on ..
GL
2016Zika vaccine shows promise in mice, lifting maker Inovio
RE
2016Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in P..
GL
2016Inovio Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
2016Sanofi launches hunt for Zika vaccine as disease fears grow
RE
2016Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS V..
GL
2016Inovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device
GL
2016INOVIO PHARMACEUTICALS : to Present at Biotech Showcase
PU
2016Inovio Pharmaceuticals to Present at Biotech Showcase
GL
2016Inovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Rela..
GL
2015Inovio Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
GL
2015GeneOne Life Science and Inovio Pharmaceuticals' MERS Vaccine Approved for First-in-Hu..
GL
2015GeneOne Life Science and the Walter Reed Army Institute of Research Partner to Develop ..
GL
2015Inovio Pharmaceuticals Reports 2015 Third Quarter Results
GL
2015Inovio's INO-3112 Shows Robust Immune Responses in Patients With Head & Neck Cancer
GL
2015Inovio Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call Nov..
GL
2015Inovio and Partner Advance MERS Vaccine
GL
2015Inovio to Participate in Upcoming Investor Conferences
GL
2015Inovio Receives $24 Million Option Grant From DARPA to Advance Ebola Program Developmen..
GL
2015Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of Its HPV Immunothe..
GL
2015Inovio's Chief Operating Officer Selected by PharmaVoice as One of the Most Inspiration..
GL
2015Inovio Pharmaceuticals Announces First Patient Dosed With Universal HIV Vaccine
GL
2015Inovio Pharmaceuticals to Participate in Citi and Rodman & Renshaw Investor Conferences
GL
2015Inovio Pharmaceuticals DNA Vaccine Protects 100% Against Deadly MERS Virus in Non-Human..
GL
2015Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License A..
GL
2015Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call Au..
GL
2015Inovio Pharmaceuticals' DNA-Based Monoclonal Antibody Protects Animals Against Lethal C..
GL
2015Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prost..
GL
2015Inovio Pharmaceuticals and European Organization for Research and Treatment of Cancer t..
GL
2015Inovio's CEO Appointed to Aspen Institute's Health Innovators Fellowship
GL
2015Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young
GL
2015Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinic..
GL
2015Inovio to Present at Jefferies Healthcare Conference
GL
2015Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola
GL
2015Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results
GL
2015Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
GL
2015Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
GL
2015Inovio Pharmaceuticals Announces Public Offering of Common Stock
GL
2015Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy..
GL
2015Inovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by W..
GL
2015Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in H..
GL
2015Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Deve..
GL
2015INOVIO PHARMACEUTICALS : Research & Clinical Trials for Prevention of Neurodegeneration Se..
PR
Prev.4  5  6  7  8   9  10Next
Upcoming event on INOVIO PHARMACEUTICALS, INC.
09/27/21